Tau PET in Alzheimer disease and mild cognitive impairment

Hanna Cho, Jae Yong Choi, Mi Song Hwang, Jae Hoon Lee, You Jin Kim, Hye Mi Lee, Chul Hyoung Lyoo, Young Hoon Ryu, Myung Sik Lee

Research output: Contribution to journalArticlepeer-review

175 Citations (Scopus)


Objective: To investigate the topographical distribution of tau pathology and its effect on functional and structural changes in patients with Alzheimer disease (AD) and mild cognitive impairment (MCI) by using 18 F-AV-1451 PET. Methods: We included 20 patients with AD, 15 patients with MCI, and 20 healthy controls, and performed neuropsychological function tests, MRI, as well as 18 F-florbetaben (for amyloid) and 18 F-AV-1451 (for tau) PET scans. By using the regional volume-of-interest masks extracted from MRIs, regional binding values of standardized uptake value ratios and volumes were measured. We compared regional binding values among 3 diagnostic groups and identified correlations among the regional binding values, performance in each cognitive function test, and regional atrophy. Results: 18 F-AV-1451 binding was increased only in the entorhinal cortex in patients with MCI, while patients with AD exhibited greater binding in most cortical regions. In the 35 patients with MCI and AD, 18 F-AV-1451 binding in most of the neocortex increased with a worsening of global cognitive function. The visual and verbal memory functions were associated with the extent of 18 F-AV-1451 binding, especially in the medial temporal regions. The 18 F-AV-1451 binding also correlated with the severity of regional atrophy of the cerebral cortex. Conclusions: Tau PET imaging with 18 F-AV-1451 could serve as an in vivo biomarker for the evaluation of AD-related tau pathology and monitoring disease progression. The accumulation of pathologic tau is more closely related to functional and structural deterioration in the AD spectrum than β-amyloid.

Original languageEnglish
Pages (from-to)375-383
Number of pages9
Issue number4
Publication statusPublished - 2016 Jul 26

Bibliographical note

Funding Information:
STUDY FUNDING This study was supported by a faculty research grant of Yonsei University College of Medicine (grant number 6-2015-0076) and a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (2015R1C1A2A01054507).

Publisher Copyright:
© 2016 American Academy of Neurology.

All Science Journal Classification (ASJC) codes

  • Clinical Neurology


Dive into the research topics of 'Tau PET in Alzheimer disease and mild cognitive impairment'. Together they form a unique fingerprint.

Cite this